|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
|
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash and cash equivalents | |||||||
| Cash | |||||||
| Note receivable | |||||||
| Short-term prepaid insurance | |||||||
| Prepaid expenses | |||||||
| Total current assets | |||||||
| Long-term prepaid insurance | |||||||
| Cash held in the Trust Account | |||||||
| TOTAL ASSETS | |||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | |||||||
| Accounts payable and accrued expenses | |||||||
| Accrued offering costs | |||||||
| Notes payable | |||||||
| Earnout Shares liability | |||||||
| FPA embedded derivative liability | |||||||
| Total current liabilities | |||||||
| Deferred underwriting fee payable | |||||||
| Deferred legal fees | |||||||
| TOTAL LIABILITIES | |||||||
| Class A ordinary shares subject to possible redemption, 19,000,000 shares at redemption value of $10.53 and $10.37 per share at June 30, 2026 and December 31, 2025, respectively | |||||||
| Common Class A | |||||||
| Total class A ordinary shares subject to possible redemption, 19,000,000 shares at redemption value of $10.53 and $10.37 per share at June 30, 2026 and December 31, 2025, respectively | |||||||
| STOCKHOLDERS’ DEFICIT | |||||||
| Class A common stock, $0.0001 par value; 500,000,000 shares authorized at September 30, 2026; 108,258,978 and 94,403,842 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively (Retroactively adjusted for recapitalization - Note 4) | |||||||
| Common Class A | |||||||
| Common Class B | |||||||
| Additional paid-in Capital | |||||||
| Accumulated deficit | |||||||
| Total stockholders’ deficit | |||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT |
Loading...